Literature DB >> 18392453

Paullinia cupana Mart var. sorbilis, guaraná, reduces cell proliferation and increases apoptosis of B16/F10 melanoma lung metastases in mice.

H Fukumasu1, J L Avanzo, M K Nagamine, J A Barbuto, K V Rao, M L Z Dagli.   

Abstract

We showed that guaraná (Paullinia cupana Mart var. sorbilis) had a chemopreventive effect on mouse hepatocarcinogenesis and reduced diethylnitrosamine-induced DNA damage. In the present experiment, we evaluated the effects of guaraná in an experimental metastasis model. Cultured B16/F10 melanoma cells (5 x 10(5) cells/animal) were injected into the tail vein of mice on the 7th day of guaraná treatment (2.0 mg P. cupana/g body weight, per gavage) and the animals were treated with guaraná daily up to 14 days until euthanasia (total treatment time: 21 days). Lung sections were obtained for morphometric analysis, apoptotic bodies were counted to calculate the apoptotic index and proliferating cell nuclear antigen-positive cells were counted to determine the proliferation index. Guaraná-treated (GUA) animals presented a 68.6% reduction in tumor burden area compared to control (CO) animals which were not treated with guaraná (CO: 0.84 +/- 0.26, N = 6; GUA: 0.27 +/- 0.24, N = 6; P = 0.0043), a 57.9% reduction in tumor proliferation index (CO: 23.75 +/- 20.54, N = 6; GUA: 9.99 +/- 3.93, N = 6; P = 0.026) and a 4.85-fold increase in apoptotic index (CO: 66.95 +/- 22.95, N = 6; GUA: 324.37 +/- 266.74 AB/mm(2), N = 6; P = 0.0152). In this mouse model, guaraná treatment decreased proliferation and increased apoptosis of tumor cells, consequently reducing the tumor burden area. We are currently investigating the molecular pathways of the effects of guaraná in cultured melanoma cells, regarding principally the cell cycle inhibitors and cyclins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18392453     DOI: 10.1590/s0100-879x2008000400008

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  4 in total

1.  Effect of Paullinia cupana on MCF-7 breast cancer cell response to chemotherapeutic drugs.

Authors:  Everaldo Hertz; Francine Carla Cadoná; Alencar Kolinski Machado; Verônica Azzolin; Sabrina Holmrich; Charles Assmann; Pauline Ledur; Euler Esteves Ribeiro; Olmiro Cezimbra DE Souza Filho; Maria Fernanda Mânica-Cattani; Ivana Beatrice Mânica DA Cruz
Journal:  Mol Clin Oncol       Date:  2014-10-08

2.  Inhibitory effects of Euphorbia tirucalli latex on murine B16/F10 melanoma cells and lung metastasis.

Authors:  Rafael Lanciani Brunetti; Diego Pinha Alves Da Paz; Ivone Izabel Mackowiak Da Fonseca; Márcia Kazumi Nagamine; Claudia Madalena Cabrera Mori; Murilo Penteado Del Grande; Nicolle Queiroz-Hazarbassanov; Cristina Oliveira Massoco Salles-Gomes; Maria Lucia Zaidan Dagli; Francisco Javier Hernandez-Blazquez
Journal:  Mol Clin Oncol       Date:  2019-09-04

3.  Evaluation of Antibacterial, Antineoplastic, and Immunomodulatory Activity of Paullinia cupana Seeds Crude Extract and Ethyl-Acetate Fraction.

Authors:  Lidiane Vasconcelos do Nascimento Carvalho; Marina Ferraz Cordeiro; Thiago Ubiratan Lins E Lins; Maria Clara Pinheiro Duarte Sampaio; Gabriela Souto Vieira de Mello; Valécia de Cassia Mendonça da Costa; Leila Larisa Medeiros Marques; Traudi Klein; João Carlos Palazzo de Mello; Isabella Macário Ferro Cavalcanti; Ivan da Rocha Pitta; Maira Galdino da Rocha Pitta; Moacyr Jesus Barreto de Melo Rêgo
Journal:  Evid Based Complement Alternat Med       Date:  2016-12-07       Impact factor: 2.629

4.  Major components of energy drinks (caffeine, taurine, and guarana) exert cytotoxic effects on human neuronal SH-SY5Y cells by decreasing reactive oxygen species production.

Authors:  Fares Zeidán-Chuliá; Daniel Pens Gelain; Eduardo Antônio Kolling; José Luiz Rybarczyk-Filho; Priscilla Ambrosi; Silvia Resende Terra; André Simões Pires; João Batista Teixeira da Rocha; Guilherme Antônio Behr; José Cláudio Fonseca Moreira
Journal:  Oxid Med Cell Longev       Date:  2013-05-22       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.